Federal bill targets menopause research and care gaps with $25M a year

What does this do?

HR 9090 directs the National Institutes of Health to expand research on symptoms linked to perimenopause, menopause, and post-menopause, including hot flashes, sleep problems, joint pain, heart disease, and cognitive and mental health changes. The bill creates grants for universities, hospitals, and research institutions to study medical and non-medical treatments, funds public education programs, and establishes Centers of Excellence at health institutions nationwide to develop best practices for menopause care. The Department of Health and Human Services would be required to report annually to Congress on progress and remaining gaps.

Who does it affect?

Women going through perimenopause and menopause, typically between their late 30s and mid-50s, are the primary population addressed, with specific attention to those in rural areas and minority communities. Health care providers including physicians, nurses, and pharmacists would also be affected through new federally funded training opportunities.

Why does it matter?

The bill responds to identified gaps in research, provider knowledge, and public information about menopausal health. Women in rural areas and underserved communities currently have less access to quality care, and the legislation directs resources toward closing those gaps.

What does it cost, and who pays?

• $25M authorized per year
• Funding runs 2027–2031
• Grants to universities and hospitals

Where does it stand?